Tag: lecanemab
Biogen Explodes on Game-Changing Alzheimer’s News
Shares of Biogen (BBIB) are up more than $93 in pre-market.
All after a substantial announcement on its Alzheimer’s drug study, in partnership with Eisai.
In...